Related Experiment Video
Updated: Oct 17, 2025

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
Machine Learning Consensus Clustering Approach for Hospitalized Patients with Phosphate Derangements
Charat Thongprayoon1, Carissa Y Dumancas1, Voravech Nissaisorakarn2
1Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 59005, USA.
Machine learning identified distinct patient groups with abnormal serum phosphate levels. These phenotypes, defined by age, comorbidities, and kidney function, showed varying mortality risks in hospitalized patients.
Area of Science:
- Nephrology
- Internal Medicine
- Data Science
Background:
- Abnormal serum phosphate levels are common in hospitalized patients.
- Understanding distinct patient phenotypes is crucial for risk stratification.
Purpose of the Study:
- To categorize hospitalized patients with hypophosphatemia and hyperphosphatemia into distinct clusters using unsupervised machine learning.
- To assess the mortality risk associated with these identified clusters.
Main Methods:
- Consensus clustering applied to demographic, comorbidity, diagnosis, and laboratory data.
- Analysis of hypophosphatemia (serum phosphate ≤ 2.4 mg/dL) and hyperphosphatemia (serum phosphate ≥ 4.6 mg/dL) cohorts.
- Standardized mean difference used to identify key cluster features and assess mortality associations.
Main Results:
- Two distinct clusters were identified in both hypophosphatemia and hyperphosphatemia cohorts.
- Hypophosphatemia Cluster 2 (older, higher comorbidity, lower eGFR, more AKI) showed higher one- and five-year mortality.
- Hyperphosphatemia Cluster 2 (older, kidney disease focus, hypertension, end-stage kidney disease, AKI, higher potassium/magnesium/phosphate) exhibited higher hospital, one-, and five-year mortality.
Conclusions:
- Machine learning successfully classified distinct clinical phenotypes in patients with serum phosphate derangements.
- Age, comorbidities, and kidney function were key differentiating features of these phenotypes.
- Phenotype identification is linked to differential mortality risks, informing clinical management.
More Related Videos
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Chronic Kidney Disease III: Interprofessional Care